Genocea announces positive top-line data from Phase 2 GEN-003 optimisation trial
20 May 2015 | By Victoria White
Genocea Biosciences has announced positive top-line data from a Phase 2 dose optimisation trial evaluating GEN-003 for the treatment of genital herpes...